Ruvastin

Ruvastin Mechanism of Action

rosuvastatin

Manufacturer:

Aristopharma

Distributor:

KTZ
Full Prescribing Info
Action
Rosuvastatin is a selective, potent and competitive inhibitor of HMG-CoA reductase effective in lowering low density lipoprotein (LDL) cholesterol and triglycerides. It produces its lipid modifying effects in two ways; firstly it increases the number of hepatic LDL receptors on the cell surface to enhance uptake and catabolism of LDL and secondly it inhibits the hepatic synthesis of very low density lipoprotein (VLDL), which reduces the total number of VLDL & LDL particles.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in